Gene · 79132
Papers3,877
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,877
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive Pan-Cancer Bioinformatics Analysis Identifies DHX58 as a Promising Therapeutic Target and Prognostic Biomarker Across Multiple Tumor Types. | Asian Pac J Cancer Prev | 2026 | 42345158 | PubTator, text mining | PubMed |
| Baicalein activates the type I interferon signaling pathway to inhibit infectious bronchitis virus infection. | Poult Sci | 2026 | 42335779 | PubTator, text mining | PubMed |
| Herpes simplex virus 1 UL2 protein inhibits RIG-I-like receptor pathway-induced IFN-β activity by disrupting IRF3 activation. | Int J Med Microbiol | 2026 | 42285021 | PubTator, text mining | PubMed |
| The assembly of stress granules during foot-and-mouth disease virus infection is uncoupled from activation of cellular intrinsic antiviral signalling. | PLoS Pathog | 2026 | 42275447 | PubTator, text mining | PubMed |
| Zapnometinib treatment and influenza A virus infection modulate the HLA class I ligandome in human lung adenocarcinoma cells. | Front Immunol | 2026 | 42273698 | PubTator, text mining | PubMed |
| Negative regulators antagonizing antitumor innate immune pathways in lung cancer immune evasion. | Front Immunol | 2026 | 42199421 | PubTator, text mining | PubMed |
| USP17L13 Enhances Influenza a Virus Replication by Mediating the Degradation of RIG-I and MDA5. | Viruses | 2026 | 42198776 | PubTator, text mining | PubMed |
| Incidence and Management Trends in Advanced Head and Neck Non-Melanoma Skin Cancer in Ontario. | Curr Oncol | 2026 | 42187608 | PubTator, text mining | PubMed |
| Multiomic characterization of response and resistance to neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma. | Transl Cancer Res | 2026 | 42180981 | PubTator, text mining | PubMed |
| ASFV early protein p30 suppresses antiviral type I IFN induction by targeting TRIM21 and RIG-I like receptor signaling adaptor MAVS. | Vet Microbiol | 2026 | 42119254 | PubTator, text mining | PubMed |
| Predicting progression of Alzheimer's disease using blood-based multi-omics data. | Bioinform Adv | 2026 | 42109582 | PubTator, text mining | PubMed |
| Suppression of Calcium Influx Reduces Coxsackievirus B3 Lethality With Elevated Interferon Beta Responses in Mice. | J Med Virol | 2026 | 42080794 | PubTator, text mining | PubMed |
| CSDE1 promotes viral immune evasion through RNA-dependent and phosphorylation-modulated liquid-liquid phase separation. | Nat Commun | 2026 | 42049720 | PubTator, text mining | PubMed |
| Updates on the role of TRIM proteins in AIDS: molecular mechanisms and potential for interventions. | Front Immunol | 2026 | 42023236 | PubTator, text mining | PubMed |
| EBV encoded tegument protein BKRF4 suppresses RLR signaling pathway-mediated interferon production through inhibiting the activation of IRF3 and IRF7. | Int J Med Microbiol | 2026 | 41996899 | PubTator, text mining | PubMed |
| ATRX loss in sarcomas is associated with dysregulated gene and transposable element expression, loss of DNA methylation, and worse survival. | ESMO Rare Cancers | 2026 | 41994103 | PubTator, text mining | PubMed |
| The human cytomegalovirus vMIA protein inhibits apoptosis and innate immune signaling in human Mueller cells. | Exp Eye Res | 2026 | 41967663 | PubTator, text mining | PubMed |
| African swine fever virus pE199L, as a mitophagy receptor, suppresses antiviral innate immunity to promote viral replication. | Autophagy | 2026 | 41937559 | PubTator, text mining | PubMed |
| Gut microbiota and pattern recognition receptors in polycystic ovary syndrome. | J Reprod Immunol | 2026 | 41935935 | PubTator, text mining | PubMed |
| Woodchuck and deer Hepatitis Delta-like agents show distinct innate immune activation and IFN-resistance compared to human Hepatitis D Virus. | Sci Rep | 2026 | 41922429 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79132/papers?page=2